InvestorsHub Logo
Followers 119
Posts 7889
Boards Moderated 0
Alias Born 09/02/2011

Re: Mistral post# 15063

Tuesday, 03/14/2017 12:47:43 PM

Tuesday, March 14, 2017 12:47:43 PM

Post# of 73619
Wrong again

Really? More patent questions?
ViaDerma has the licence to sell under the original patent.

He has also filed 2 new patent pending applications.

Post conference price target = .10-12+

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

January 11, 2017
~Filed a patent application with the USPTO for its proprietary innovative transdermal delivery system~
http://www.marketwired.com/press-release/viaderma-incs-ceo-files-new-patent-application-signs-two-licensing-deals-locates-product-otc-pink-vdrm-2187878.htm

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129386093
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129283860


November 30, 2016
"Patent Pending Transdermal System" can deliver medications and nutrients into the body through the skin. The solution combined with FDA registered drugs can increase the absorption as much as 100 times directly to the localized treatment areas,
http://www.marketwired.com/press-release/viaderma-inc-clinical-studies-abroad-europe-middle-east-asia-show-promising-results-otc-pink-vdrm-2179850.htm


November 14, 2016
Filed Patent Pending use of its innovative transdermal system for the delivery of (CBD's) Calanoids and (THC) Tetrahydrocannabinol for the treatment of several diseases
http://www.marketwired.com/press-release/viaderma-inc-enters-mmj-medical-marijuana-industry-with-patent-pending-cbd-delivery-otc-pink-vdrm-2175498.h